Antimicrobial Agents in Clinical Treatment

It is an analysis of the antibacterial clinical development pipeline, including mycobacterium tuberculosis. Resistance is a natural phenomenon which will develop by time. As misuse and overuse of antibiotics at accelerate the development of resistance. Antibiotics should be used for antibacterial treatment. The lack of new quality lead chemicals to test against gram-ve bacteria is another major impediment to discovery.

 

  • Vaccines against human papillomavirus
  • Phytotherapy
  • Ethnopharmacology

Related Conference of Antimicrobial Agents in Clinical Treatment

February 27-28, 2019

2nd Global Experts Meeting on Infectious Diseases

| Radisson Hotel Narita | Tokyo, Japan
March 13-14, 2019

12th World Congress on Virology and Infectious Diseases

| Holiday Inn Atrium | Singapore
April 08-09, 2019

2nd Global experts meet on STD-AIDS and Infectious Diseases

Wellington, New Zealand
June 17-18, 2019

9th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
July 29-30, 2019

Annual Meeting on Infectious Diseases

Amsterdam, Netherlands
September 09-10, 2019

12thGlobal Infections Conference

Holiday Inn Atrium | Singapore
September 16-17, 2019

10th International Conference on Emerging Infectious Diseases

Brussels, Belgium
September 23-24, 2019

10th Annual Congress on Rare Diseases and Orphan Drugs

Toronto | Canada
September 23-24, 2019

11th Euro-Global Conference on Infectious Diseases

London, UK
October 21-22, 2019

9th Asia Pacific STD and Infectious Diseases Congress

Hotel Radisson | Tokyo Japan
November 19-20, 2019

7th Annual Conference on Parasitology & Infectious Diseases

Cape Town, South Africa

Antimicrobial Agents in Clinical Treatment Conference Speakers

Recommended Sessions

Related Journals

Are you interested in